CANCER – 2025
Dates: April 25, 2025
Main topics:
This meeting will serve as a valuable forum for the presentation
and discussion of newly available data across various
malignancies including all cancers.
Participants will be provided with updates on practice-changing data
in a practical and interactive format, fostering discussion,
and impacting clinical outcomes for patients.
Programme:
Day 1 – Optimising Clinical Development in Oncology
-
- Targeted therapies in clinical development; antibody, vaccines & cell-based therapies
- Overcoming the mechanisms of cancer drug resistance
- Co-development of combined oncology therapies
- Identifying appropriate clinical endpoints
- Strategies to reach critical go/no-go decisions earlier
- Novel technologies for imaging in drug development
- Pharmacovigilance & patient safety
- Integrating biomarkers in clinical development & trials
Day 2 – Operational Challenges of Oncology Clinical Trials
-
- Establishing the correct trial population; emerging markets, global trials
- Adaptive clinical trial design
- Appropriate site selection
- Regulatory considerations
- Clinical trial management
- Patient recruitment and retention strategies
- Successfully maintaining CRO relationships
- Effective use of clinical data & eClinical solutions
Call for abstracts
Deadline for submission: 10/09/2024
The late abstract should contain newly achieved scientific work and results. The abstract has to be one full page (size A4, 210 x 297 mm) plus 1 to 3 explanatory pages with more detailed information about the work.
The abstract written in English and single spaced should include:
- Applicable topic
- Full title
- Full name, affiliation, address, phone/fax/e-mail of one author for all correspondence
- For all other co-authors, full name, affiliation and e-mail
- Short introductive summary (approx. 1,000 characters) for publication in the Programme Planner
- Purpose of the work
- Approach
- Scientific innovation and relevance
- Results and Conclusions
For questions concerning abstracts, please contact:
| [email protected] |
The attendees of this event will get a chance to take part in:
- master class on modern instrumental methods of diagnostics of rheumatic diseases- ultrasounds, MRI, osseo densitometry.
- master class on increasing effective drug treatment of patients with rheumatic diseases.
Conditions of participation for participants:
Registration Package includes certificate of participation (English language) ,participation in scientific sessions, conference materials, visit to the exhibition and 10-30% discount for accomodation in hotel.
Online registration is required.No admission without registration confirmation.
(deadline – November 01, 2024)
The information on this page is intended for scientific, educational, and general informational purposes. Clinical approaches, availability, and regulatory status may vary by country, institution, and medical indication. For individual medical decisions, readers should consult qualified healthcare professionals and accredited medical centers.
This article has been prepared by the NBScience editorial team within the scope of clinical research, biotechnology, and international medical information.
